View Older Stories View More Recent Stories

Nov 1, 2023 04:01PM Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023
Oct 30, 2023 04:30PM Immunocore to present at upcoming investor conferences
Oct 21, 2023 08:45AM Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial
Oct 6, 2023 07:01AM Immunocore announces upcoming presentation and posters at ESMO 2023
Sep 11, 2023 05:00PM Immunocore to present at upcoming investor conferences
Sep 1, 2023 04:00PM Immunocore to present at upcoming investor conferences
Aug 10, 2023 07:00AM Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update
Aug 3, 2023 08:00AM Immunocore to report second quarter 2023 financial results and host call on August 10, 2023
Jul 27, 2023 09:15AM The Galien Foundation Announces 2023 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product" and "Best Product for Rare/Orphan Diseases"
Jun 5, 2023 05:53AM Immunocore (IMCR) Presents Additional ctDNA Phase 3 Data
Jun 3, 2023 07:00AM Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
Jun 1, 2023 04:30PM Immunocore to present at upcoming investor conferences
Jun 1, 2023 04:30PM Immunocore to present at upcoming investor conferences
May 10, 2023 07:00AM Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update
May 3, 2023 04:30PM Immunocore to present at the Bank of America Securities 2023 Health Care Conference
Apr 18, 2023 07:03AM Immunocore (IMCR) Presents New KIMMTRAK Data
Apr 18, 2023 07:00AM Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
Apr 11, 2023 07:00AM Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
Apr 11, 2023 07:00AM Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
Mar 23, 2023 09:00AM Outpace Bio, a Leader in Protein Design & Cell Engineering, Adds Bahija Jallal to Board of Directors
Mar 14, 2023 04:30PM Immunocore to present four posters at AACR Annual Meeting 2023
Mar 14, 2023 04:30PM Immunocore to present four posters at AACR Annual Meeting 2023
Mar 14, 2023 08:00AM Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
Mar 1, 2023 07:00AM Immunocore Reports 2022 Financial Results and Provides Business Update
Mar 1, 2023 07:00AM Immunocore Reports 2022 Financial Results and Provides Business Update
Feb 28, 2023 07:00AM Immunocore to present at upcoming investor conferences
Feb 28, 2023 07:00AM Immunocore to present at upcoming investor conferences
Feb 23, 2023 07:00AM Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023
Feb 23, 2023 07:00AM Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023
Feb 22, 2023 07:01AM Immunocore (IMCR) Reports Initial Phase 1 Data for TCR Therapy
Feb 22, 2023 07:00AM Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
Feb 22, 2023 07:00AM Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
Feb 1, 2023 07:00AM Immunocore to present at upcoming investor conferences
Feb 1, 2023 07:00AM Immunocore to present at upcoming investor conferences
Jan 9, 2023 07:00AM Immunocore announces strategic priorities including pipeline expansion for 2023 -2024
Jan 9, 2023 07:00AM Immunocore announces strategic priorities including pipeline expansion for 2023 -2024
Jan 4, 2023 07:00AM Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference
Jan 4, 2023 07:00AM Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference
Dec 15, 2022 06:00AM Immunocore is awarded the Prix Galien France award for KIMMTRAK
Dec 15, 2022 06:00AM Immunocore is awarded the Prix Galien France award for KIMMTRAK
Dec 14, 2022 03:00AM Etcembly Announces Breakthrough in Optimising TCR Assets
Dec 8, 2022 06:30AM Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
Dec 8, 2022 06:30AM Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
Dec 2, 2022 07:31AM Immunocore (IMCR) and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
Dec 2, 2022 07:30AM Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
Dec 2, 2022 07:30AM Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
Nov 23, 2022 07:00AM Immunocore to present at the 5th Annual Evercore ISI HealthCONx Conference
Nov 23, 2022 07:00AM Immunocore to present at the 5th Annual Evercore ISI HealthCONx Conference
Nov 11, 2022 09:00AM Immunocore (IMCR) Presents New KIMMTRAK Biomarker Analysis
Nov 11, 2022 09:00AM Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
View More Recent Stories View Older Stories